Target intelligence / Profile preview

Sodium-hydrogen exchange regulatory cofactor NHE-RF2 (NHERF2)

Target
NHERF2
Molecular classification
PDZ domain scaffold protein, Adapter protein, Other (not an enzyme, receptor, ion channel, transporter, or transcription factor)
01

Overview

Sodium-hydrogen exchange regulatory cofactor NHE-RF2 (NHERF2) is a PDZ domain-containing scaffold protein encoded by the SLC9A3R2 gene. It organizes membrane protein complexes by connecting plasma membrane proteins (such as NHE3 and CFTR) with cytoskeletal proteins from the ezrin/moesin/radixin family, linking them to the actin cytoskeleton and regulating their membrane expression and function[4][7]. NHERF2 is crucial for cAMP-mediated phosphorylation and inhibition of the sodium/hydrogen exchanger NHE3, thus playing a significant role in intestinal and renal sodium absorption and homeostasis[4][7]. It may also act as a nuclear scaffold protein[4]. Its interactions regulate cystic fibrosis transmembrane conductance regulator (CFTR) activity, calcium signaling via mGluR5, cell adhesion, and cell proliferation[2][5][1]. NHERF2 is implicated in several diseases through these functions, most notably cystic fibrosis and vascular/endothelial disorders[7][5]. Disruption or modulation of NHERF2 scaffolding interactions has been proposed for therapeutic intervention in CFTR-related diseases and inflammation[1][3].

Other names
Na(+)/H(+) exchange regulatory cofactor NHE-RF2SLC9A3R2NHERF-2SIP-1TKA-1E3KARP (NHE3 kinase A regulatory protein)SRY-interacting protein 1Sodium-hydrogen exchanger regulatory factor 2Solute carrier family 9 isoform A3 regulatory factor 2Tyrosine kinase activator protein 1OCTS2NHE3RF2
02

Mechanism of action

Modulation/Disruption of PDZ domain-mediated scaffolding to alter protein complex formation and downstream signaling; Inhibition or enhancement of binding to cystic fibrosis transmembrane conductance regulator to regulate chloride transport; Targeting its interaction with NHE3 to alter sodium absorption.

03

Biological functions

Signal transductionCell surface expression regulationScaffold-mediated protein complex assemblycAMP-mediated phosphorylation (of SLC9A3/NHE3)Intestinal sodium absorptionCFTR (cystic fibrosis transmembrane conductance regulator) regulationCytoskeletal regulation (via ezrin/moesin/radixin family linking)Regulation of Ca2+ signaling through interaction with mGluR5Negative regulation of endothelial proliferation
04

Disease associations

Cystic fibrosis (modulates CFTR activity)Inflammatory disease (involved in neutrophil migration)Spinocerebellar ataxia, X-linked 3 (gene association)Endothelial dysfunction/vascular modeling (negative regulator role)Potential roles in cancer (by scaffolding oncoproteins and influencing cell signaling)
05

Safety considerations

Therapeutic modulation may affect epithelial ion transport and fluid homeostasis, resulting in electrolyte imbalanceModulation could influence CFTR-related mechanisms, potentially affecting cystic fibrosis treatment efficacyGeneral risk due to involvement in multiple signaling complexes—off-target effects are plausible
06

Interacting drugs

No specific drugs directly targeting NHERF2 are established or approved; however, its role affects the pharmacology of drugs acting on NHE3, CFTR, and membrane receptors. Drugs modulating CFTR (such as ivacaftor, lumacaftor) may be indirectly affected.
07

Biomarkers

NHERF2 expression or genetic status could serve as a biomarker for CFTR function and cystic fibrosis pharmacologic responseNHERF2 might be biomarker for endothelial proliferation or vascular remodeling disordersNo companion diagnostic biomarker is clinically established.

Beyond the preview

Go deeper on Sodium-hydrogen exchange regulatory cofactor NHE-RF2 (NHERF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-hydrogen exchange regulatory cofactor NHE-RF2 (NHERF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call